JPRN-UMIN000009240招募中3 期
Trial of Prevention of Irritable Bowel Syndrome by Smoking Cessation - Smoking Cessation for IBS
Tohoku University Graduate School of Medicine0 个研究点目标入组 1,200 人开始时间: 2012年11月26日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 1,200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •IBS subjects Patients with psychosis Patients with personality disorders
研究者
相似试验
已完成
1 期
Investigation of Efficacy and Safety of PPC-5650 to Experimental Induced Sensation and Pain in the RectosigmoidPainNCT01449487Aros Pharma ApS25
已完成
不适用
Culturally Adapted Psychological Intervention for the Management of Irritable Bowel Syndrome (IBS)Irritable Bowel SyndromeNCT03379064Pakistan Institute of Living and Learning45
进行中(未招募)
1 期
Management of Irritable Bowel Syndrome in Primary Care: Feasibility randomised controlled trial of mebeverine, methylcellulose, placebo and a patient self-management cognitive behavioural therapy website. (MIBS Trial) - Management of Irritable Bowel Syndrome in Primary Care: RCT (MIBS)Irritable Bowel SyndromeEUCTR2009-013426-16-GBniversity of Southampton150
尚未招募
不适用
Treatment of irritable bowel syndrome: Using dietary carbohydrate restriction and hypnotherapy as complementary therapiesIrritable bowel syndromeOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonACTRN12612000585820Monash University78
Unknown
2 期
The Effect of Coltect (Selenium, Curcumin and Green Tea) on Irritable Bowel SyndromeIrritable Bowel SyndromeNCT01167673NAFTALI TIMNA40
